Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1633
    -0.0051 (-0.43%)
     
  • GBP/USD

    1.2398
    -0.0041 (-0.33%)
     
  • Bitcoin GBP

    52,072.05
    +895.00 (+1.75%)
     
  • CMC Crypto 200

    1,334.09
    +21.46 (+1.66%)
     
  • S&P 500

    4,984.58
    -26.54 (-0.53%)
     
  • DOW

    37,941.40
    +166.02 (+0.44%)
     
  • CRUDE OIL

    83.04
    +0.31 (+0.37%)
     
  • GOLD FUTURES

    2,409.90
    +11.90 (+0.50%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

AstraZeneca’s Valuation after 3Q17 Earnings

In 3Q17, AstraZeneca reported EPS of $0.56 on revenues of $6.2 billion compared to estimates of $0.71 for EPS on revenues of $6 billion.